Related Experiment Video

Updated: Jun 21, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Congenital heart disease in pregnancy

Anselm Uebing, Michael A Gatzoulis, Constantin von Kaisenberg

    Deutsches Arzteblatt International
    |July 25, 2009
    PubMed

    Insights

    Women with congenital heart disease (CHD) face risks during pregnancy due to cardiovascular changes. Optimal multidisciplinary care ensures successful pregnancies for most women with CHD.

    Area of Science:

    • Cardiology
    • Obstetrics
    • Maternal Health

    Background:

    • Pregnancy induces significant cardiovascular changes, increasing risks for women with congenital heart disease (CHD).
    • Advances in pediatric cardiac care allow more individuals with CHD to reach adulthood and consider pregnancy.
    • Congenital heart disease is a primary cause of maternal mortality in industrialized nations.

    Purpose of the Study:

    • To review the management of pregnancy in women with congenital heart disease.
    • To highlight the importance of specialized care for pregnant women with CHD.

    Main Methods:

    • A selective literature review was conducted.

    Main Results:

    • Pregnancy presents substantial physiological cardiovascular challenges for women with CHD.
    • Congenital heart disease is a leading cause of maternal death.

    Conclusions:

    • Optimal pregnancy outcomes for women with CHD necessitate a multidisciplinary team approach.
    • Comprehensive counseling and specialized care enable most women with CHD to have successful pregnancies with minimized risk.
    Abstract

    Keywords:
    congenital heart diseasematernitymultidisciplinary care

    More Related Videos

    Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

    Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

    Published on: March 10, 2020

    In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography08:01

    In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography

    Published on: November 22, 2013

    Related Concept Videos

    Mitral Valve Prolapse III: Nursing Management01:19

    Mitral Valve Prolapse III: Nursing Management

    The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Rheumatic Heart Disease I: Introduction01:23

    Rheumatic Heart Disease I: Introduction

    Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
    Mitral Regurgitation I: Introduction01:20

    Mitral Regurgitation I: Introduction

    Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
    Fetal Circulation01:14

    Fetal Circulation

    Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
    Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...